In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 1.07 below Nautilus Biotechnology Inc average.

Within Laboratory Analytical Instruments industry 11 other companies have achieved higher Quick Ratio than Nautilus Biotechnology Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 297 to 1628.

Explain Quick Ratio?
How much Cash & cash equivalents NAUT�s has?
What are NAUT�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/NAUT/financial-strength

https://api.csimarket.com/api/v1/companies/NAUT/fundamentals

https://api.csimarket.com/api/v1/companies/NAUT/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

NAUT Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	8.64 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-92.04 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	1.07	Subscribe	Subscribe	Subscribe	Subscribe
NAUT's Total Ranking	# 1628	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	12.95 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-20.5 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 12
Healthcare Sector	# 561
Overall Market	# 1628

Quick Ratio Statistics
High	Average	Low
303.62	38.7	0.39
(Jun 30 2021)		(Mar 31 2021)

Financial Statements
Nautilus Biotechnology Inc 's Current Liabilities	$ 10 Millions	Visit NAUT's Balance sheet
Nautilus Biotechnology Inc 's Cash & cash equivalent	$ 10 Millions	Visit NAUT's Balance sheet
Source of NAUT's Sales		Visit NAUT's Sales by Geography

Cumulative Nautilus Biotechnology Inc 's Quick Ratio

NAUT's Quick Ratio for the trailling 12 Months

NAUT Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	5.42 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-30.92 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	10.91	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 3831	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	2.29 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-24.21 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to NAUT Financial Strength Comparisons >> Go to Compare NAUT Quick Ratio to its Competitors

On the trailing twelve months basis Due to increase in Current Liabilities in the Q3 2026 to $9.76 millions, cumulative Quick Ratio decreased to 10.91 below the Nautilus Biotechnology Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Nautilus Biotechnology Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2542 to 3831.

Explain Quick Ratio?
How much Cash & cash equivalents NAUT�s has?
What are NAUT�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 22
Healthcare Sector	# 884
Within the Market	# 3831

trailing twelve months Quick Ratio Statistics
High	Average	Low
70.73	16.17	1.89
(Mar 31 2022)		(Jun 30 2026)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Laboratory Analytical Instruments Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Cytek Biosciences Inc	2.58	$ 255.899 Millions	$ 99.179 Millions
Quanterix Corporation	1.51	$ 77.359 Millions	$ 51.130 Millions
Nautilus Biotechnology Inc	1.07	$ 10.467 Millions	$ 9.758 Millions
Bio rad Laboratories Inc	0.86	$ 837.100 Millions	$ 969.100 Millions
Avantor Inc	0.34	$ 464.300 Millions	$ 1,369.000 Millions

Date modified: 2026-10-28T09:26:49+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.